top of page
Image by Braňo
Latest News
Post: Blog2_Post

SACRA Conference 2023

Conference Theme: Converge for Africa

Dates: 1 - 3 November 2023

Venue: Future Africa Campus, University of Pretoria

Address: South St, Koedoespoort 456-Jr, Pretoria, 0186

Conference Registration Fees:

SACRA Members Fees: R3500

Non Members Fees: R4500

Discover the Road to Progress: Join SACRA at the most anticipated conference of the year! Immerse yourself in a world of ground-breaking strides made for the future of clinical trials in South Africa and Sub Saharan Africa. Gain valuable insights from industry stakeholders, explore revolutionary technologies, and connect with potential collaborators, colleagues, and industry leaders. Get ready to unlock new frontiers and pave the way for clinical trials in South Africa and beyond. Stay tuned for more information to follow soon regarding a conference that will leave a lasting impact on all participants, shaping the future of research in South Africa & Africa.

Secure your spot at the upcoming conference on clinical trials in Sub Saharan Africa and take advantage of exclusive benefits. Register to enjoy discounted rates and special perks. Don't miss this opportunity to be part of the pioneering discussions and network with industry leaders. Act now to reserve your place!

Professor Glenda Gray Bio:

An NRF A1 rated scientist, CEO and President of the South African Medical Research Council (SAMRC), Professor Glenda Gray is a qualified pediatrician and co-founder of the internationally recognised Perinatal HIV Research Unit in Soweto, South Africa. Prior to her appointment at the SAMRC, she was the Executive Director of the Perinatal HIV Research Unit, an affiliate of Wits University. Glenda’s global profile includes a role as Co-PI of the HIV Vaccine Trials Network (HVTN), an international collaboration for the development of HIV/AIDS prevention vaccines.

As the COVID-19 pandemic developed, she was among the first to lead public discourse on the issue, and to move quickly to establish COVID-19 vaccine trials in South Africa, utilizing the experience and network developed over the years for the HIV vaccine work. Glenda served as a Protocol Co-Chair of the multi-country Ensemble Study investigating the single-dose Ad26.COV2.S vaccine as an emergency response intervention. When South Africa’s national vaccine roll-out faltered, her international stature enabled her to negotiate a donation of 500 000 doses of the Ad26.CoV.2 vaccine before any emergency use authorization was available and conduct a phase 3B open-label study in health care workers, called the Sisonke Study.

She received South Africa’s highest honour – the Order of Mapungubwe - for her pioneering research in PMTCT. Other prestigious accolades include the Nelson Mandela Health and Human Rights Award for significant contributions in the field of mother-to-child transmission of HIV. Selected as one of Time’s 100 Most Influential People in the World, Forbes top 50 women in Africa, honorary degrees include: DSc (honoris causa Simon Fraser University), DSc (honoris causa Stellenbosch University), and LLD (honoris causa Rhodes University). She is a member of the National Academy of Medicine, the Academy of Science of South Africa, the African Academy of Science and the World Academy of Science. She is fellow of the American Academy of Microbiology.She is a member of the board of GARDP, AAHI and a member of the WHO TB-STAG.

Dr. Bernhards Ragama Ogutu Bio:

Dr. Ogutu is a Kenyan Paediatrician and Clinical Pharmacologist. Senior Principal Clinical Scientist with the Kenya Medical Research Institute (KEMRI) and the scientific team leader of the Centre for Research in Therapeutic Sciences (CREATES)- Strathmore University. Dr. Ogutu received MBChB, MMed and PhD from the University of Nairobi and is a certified Physician Investigator. Dr. Ogutu has held different positions since 1992 from practicing paediatrics at several hospitals and lead clinical trialist in a number of product evaluation protocols. His areas of research include clinical trials, disease pathogenesis, clinical therapeutics with a bias in malaria and clinical trials capacity development in Africa.

Click on each image below to read full bio-sketches of our Guest Speakers (watch this space as more bios will be added soon):

SACRA Panellists Particpating:


(Slide through below image gallery - click on image to visit exhibitor websites)


Please click on this link to RSVP:

bottom of page